Article ID Journal Published Year Pages File Type
1883369 Radiation Physics and Chemistry 2014 4 Pages PDF
Abstract

•Patient effective doses were evaluated for CT urography and intravenous urography.•Radiation doses were measured using a calibrated TLD GR200A and calibrated dose descriptors annexed to the CT machines.•Patient effective dose and radiation cancer risks are low compared to the previous studies.•The effective dose from CTU procedures was 30% higher compared to IVU procedures.•Wide dose variation between patient doses suggests that optimization is not fulfilled yet.

Intravenous urography (IVU) and CT urography (CTU) are efficient radiological examinations for the evaluation of the urinary system disorders. However patients are exposed to a significant radiation dose. The objectives of this study are to: (i) measure and compare patient radiation dose by computed tomography urography (CTU) and conventional intravenous urography (IVU) and (ii) evaluate organ equivalent dose and cancer risks from CTU and IVU imaging procedures. A total of 141 patients were investigated. A calibrated CT machine (Siemens-Somatom Emotion duo) was used for CTU, while a Shimadzu X ray machine was used for IVU. Thermoluminescence dosimeters (TLD-GR200A) were used to measure patients' entrance surface doses (ESD). TLDs were calibrated under reproducible reference conditions. Patients radiation dose values (DLP) for CTU were 172±61 mGy cm, CTDIvol 4.75±2 mGy and effective dose 2.58±1 mSv. Patient cancer probabilities were estimated to be 1.4 per million per CTU examination. Patients ESDs values for IVU were 21.62±5 mGy, effective dose 1.79±1 mSv. CT involves a higher effective dose than IVU. In this study the radiation dose is considered low compared to previous studies. The effective dose from CTU procedures was 30% higher compared to IVU procedures. Wide dose variation between patient doses suggests that optimization is not fulfilled yet.

Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , ,